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A B S T R A C T   
Background: Associations between physical activity (PA) and subclinical anxiety disorder symptoms and status, 
and potential mediating effect of social physique anxiety (SPA), remain understudied. We examined associations 
between PA and analogue Generalized Anxiety Disorder (AGAD), analogue Social Anxiety Disorder (ASAD), and 
analogue Panic Disorder (APD) symptoms and status, the mediating effect of SPA, and sex-related differences. 
Methods: Participants (n = 470, 23.2 ± 4.8 years, 298 female) completed the Psychiatric Diagnostic Screening 
Questionnaire, seven-day PA recall, and Social Physique Anxiety Scale. ANCOVA examined differences in SPA 
and anxiety disorder symptoms between PA levels. Logistic regression examined associations between PA and 
analogue anxiety disorder status. Mediation analyses estimated the effect of change in PA on analogue anxiety 
disorder odds when SPA was at its mean. 
Results: AGAD, ASAD, and APD prevalence was 38.1%, 60.0%, and 15.1%, respectively. AGAD and ASAD 
symptoms, but not APD symptoms, were significantly lower among higher PA levels. PA was associated with 
lower odds of AGAD, ASAD, and APD; findings were not significant after adjustment. The pure indirect effect of 
SPA significantly accounted for 58.2% and 47.9% of the total effect of PA on AGAD and ASAD, respectively; 
findings were not significant after adjusting for depression. Females showed greater odds of AGAD, ASAD, and 
APD; mediation findings did not differ based on gender. 
Limitations: Cross-sectional design, self-reported exposure and outcomes, and sample size are potential 
limitations. 
Conclusion: Symptoms and odds of AGAD and ASAD status were lower among young adults with greater PA; SPA 
partially mediated associations and warrants experimental investigation.   
1. Introduction 
Anxiety disorders are prevalent, debilitating, and costly public 
health problems, affecting an estimated 264 million people and 
approximately twice as many females than males (WHO, 2017). Anxiety 
disorders are the sixth leading contributor to global disability (Baxter 
et al., 2013, 2014; Gustavsson et al., 2011; Remes et al., 2016), are 
frequently comorbid with other physical and mental illnesses (Van-
campfort et al., 2017), and treatment success is limited (Boschen et al., 
2009; Carpenter et al., 2018; De Vries et al., 2016). 
Regular physical activity (PA) is a potentially low-cost, low-risk, 
alternative or augmentation therapy for anxiety disorders. Robust evi-
dence has supported that regular PA and exercise have potential pro-
tective and therapeutic benefits for anxiety symptoms and disorders 
(Gordon et al., 2017; Herring et al., 2012; Herring et al., 2014a; Herring 
et al., 2010; McDowell et al., 2019). Despite this, those with elevated 
anxiety tend to be less physically active, with females consistently 
reporting lower PA levels than males (Hallgren et al., 2019; McDowell 
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et al., 2018). Available evidence for the protective benefits of PA for 
anxiety disorders has largely focused on Generalized Anxiety Disorder 
(GAD), with recent meta-analytic evidence showing 45.7% lower odds 
of developing GAD among physically active older adults (McDowell 
et al., 2019). However, associations between PA and anxiety disorder 
symptoms and status remain understudied, particularly among younger 
adults who are at higher risk for development of anxiety symptoms and 
disorders (Kessler et al., 2007). 
Moreover, there is continued interest in exploration of modifiable 
factors that may influence PA, anxiety disorders, and their associations 
to inform intervention development and personalized prescription of PA 
to improve mental health. Social Physique Anxiety (SPA), anxiety 
resulting from the prospect or presence of interpersonal evaluation of 
one’s physique, is a construct related to body image and body esteem 
(Hart et al., 1989). SPA has been inversely associated with PA motiva-
tion and behaviour (Baillot et al., 2020; Brunet and Sabiston, 2009), 
particularly feelings of incompetence in PA contexts (Kowalski et al., 
2001) and the social and evaluative nature of PA settings (Sabiston et al., 
2014). SPA also has been negatively associated with mental health. For 
example, 693 patients with mental illness reported higher levels of social 
anxiety in PA contexts compared to 2888 healthy controls (De Herdt 
et al., 2013). Even among regularly physically active individuals 
without a mental illness, SPA has negatively influenced mental health, 
primarily through increased psychological inflexibility (Alcaraz-Ibáñez 
et al., 2017). Given associations between SPA and both PA and mental 
health, it is plausible that SPA accounts for variability in the association 
between PA and mental health outcomes. However, the potential 
moderating and/or mediating effect of SPA on the associations between 
PA and anxiety disorders remains understudied. Mediation analyses 
require that several assumptions are met, including that the exposure 
plausibly precedes the outcome, and establishing temporality in 
cross-sectional mediation designs can be difficult. However, there is 
strong epidemiological (McDowell et al., 2019) and experimental 
(Herring et al., 2012) evidence to support that this is the case for the 
PA—Anxiety Disorder relationship. 
Thus, the objectives of this cross-sectional investigation were to: a) 
quantify the associations between PA and subclinical, or analogue 
Generalized Anxiety Disorder (AGAD), analogue Social Anxiety Disorder 
(ASAD), and analogue Panic Disorder (APD) symptoms and status, b) 
examine SPA as a mediator of these associations, and c) explore po-
tential sex-related differences. 
Based on the current literature, we hypothesised that: a) active 
young adults would report significantly lower AGAD, ASAD, and APD 
symptoms and lower odds of AGAD, ASAD, and APD statuses; b) SPA 
would significantly mediate associations between PA and AGAD, ASAD, 
and APD symptoms and statuses; and, c) associations between PA and 
AGAD, ASAD, and APD symptoms and status and the mediating influ-
ence of SPA on these associations would be stronger among females than 
males. 
2. Methods 
2.1. Participants recruitment 
This study protocol was approved by the University’s Research 
Ethics Board. Four hundred eighty-six participants were recruited from 
the surrounding area via posters, emails, and word of mouth to complete 
an electronically-administered physical activity and mood survey as part 
of the screening process for an on-going randomized controlled trial. 
Inclusion criteria included age of 18–40 years, completion of the online 
battery of questionnaires, and willingness for data to be analysed. Par-
ticipants were not compensated for participation. Sixteen respondents 
outside the age range were excluded, resulting in a sample size of 470 for 
the study reported herein (Gordon et al., 2020). 
2.2. Exposure, outcomes, and covariates 
2.2.1. Analogue anxiety disorder symptoms and statuses 
AGAD, ASAD, and APD symptoms and status were assessed with the 
10-item GAD, 15-item SAD, and 8-item PD subscales of the Psychiatric 
Diagnostic Screening Questionnaire, respectively (Zimmerman and 
Mattia, 2001b). AGAD, ASAD, and APD status were classified using 
validated cut-scores of ≥6 on the PDSQ-GAD and ≥4 for both the 
PDSQ-SAD and PDSQ-PD subscales (Zimmerman and Mattia, 2001a). 
The PDSQ-GAD, PDSQ-SAD, and PDSQ-PD have sensitivity/specificity 
of 95/41%, 91/69%, and 91/63%, respectively. Internal consistency in 
the current sample was Cronbach’s α = 0.87 (ICC: 0.87, 95%CI: 0.85, 
0.88), Cronbach’s α = 0.88 (ICC: 0.87, 95%CI: 0.84, 0.89), and Cron-
bach’s α = 0.84 (ICC: 0.84, 95%CI: 0.81, 0.86) for PDSQ-GAD, 
PDSQ-SAD, and PDSQ-PD, respectively. 
2.2.2. Physical activity 
PA was assessed using a seven-day Physical Activity Recall (Blair 
et al., 1985). Participants self-reported time engaged in sleep, moderate, 
hard, and very hard physical activities over the prior seven days. Values 
of 1, 1.5, 4, 6, and 10 metabolic equivalents (METs; i.e., the ratio of 
energy expenditure in kilocalories divided by resting energy expenditure 
in kilocalories) were assigned to sleep, light, moderate, hard, and very 
hard activities, respectively. Estimated energy expenditure was 
expressed as kilocalories per week. Because weight was self-reported, 
and self-reports of weight are often biased, weight was not factored 
into MET estimates; rather, standard procedures for MET estimates and 
estimates of overall energy expenditure from the seven-day physical 
activity recall were used. Based on thresholds validated among univer-
sity students (Dishman and Steinhardt, 1988), estimated energy 
expenditure levels of <245 kcal/wk were classified as low-active, 245 
kcal/wk to <280 kcal/wk were classified as moderately-active, and 
≥280 kcal/wk were classified as highly-active. 
2.2.3. Social physique anxiety 
SPA was measured with the 12-item Social Physique Anxiety Scale 
(SPAS) (Hart et al., 1989). The SPAS examines the extent to which 
people become anxious when others evaluate their physiques; it has 
demonstrated strong psychometric properties, including high internal 
consistency and content and logical validity (Hart et al., 1989). The 
SPAS demonstrated strong internal consistency in the current sample 
(Cronbach’s α = 0.93; ICC: 0.91, 95%CI: 0.89, 0.93). Approximately 1% 
of the sample (n = 5) were missing SPA data and were excluded from 
analyses that included SPA. 
2.2.4. Symptoms of major depressive disorder 
To facilitate sensitivity analyses, symptoms of Major Depressive 
Disorder (MDD), or depressive symptoms, were quantified with the 21- 
item PDSQ-MDD subscale (Zimmerman and Mattia, 2001b), which has 
sensitivity/specificity of 90%/67% and demonstrated adequate internal 
consistency of Chronbach’s α = 0.83 (ICC: 0.80, 95%CI: 0.77, 0.83). 
2.3. Statistical analyses 
Statistical analyses were conducted using SPSS Version 26.0 
(Armonk, NY: IBM Corp.) and Stata 14.0 (StataCorp for Windows). 
ANCOVA adjusted for age and gender, with Bonferroni-corrected post- 
hoc tests, examined differences in SPA and anxiety disorder symptoms 
between PA levels. The magnitude of differences were quantified using 
Cohen’s d; positive effect sizes represented improved outcomes. Effects 
of 0.2, 0.5, and 0.8 were appraised as small, moderate, and large, 
respectively. Logistic regression examined associations between PA 
level and analogue anxiety disorder status. Crude models and models 
adjusted for age, gender, and smoking status are reported. 
Mediation analyses were performed using the Stata command 
med4way to estimate the effect of change in PA level (from low-active to 
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highly-active) on odds of AGAD, ASAD, and APD when SPA was at its 
mean and covariates were adjusted in the model (Discacciati et al., 2019; 
VanderWeele, 2015). This mediation method has been applied in 
epidemiological studies where exposure and mediator variables are 
measured concurrently (Hallgren et al., 2020). The overall effect of the 
exposure on the outcome, in the presence of the mediator with which the 
exposure may interact, is decomposed into four components: how much 
of the effect is due to (1) the controlled direct effect (neither mediation 
nor interaction), (2) reference interaction (the interaction only), (3) 
mediated interaction (both mediation and interaction), and (4) the pure 
indirect effect (mediation only; see Table 1). When statistically signifi-
cant, the pure indirect effect indicated a potential mediating effect of 
SPA. Causal effects were estimated for a change in PA from low-active to 
highly-active and at the mean level of the covariates. The controlled 
direct effect was computed fixing SPA at its mean. As sensitivity ana-
lyses, mediation models were rerun, additionally controlling for symp-
toms of Major Depressive Disorder. 
3. Results 
Table 2 presents participant characteristics. Prevalence rates of 
AGAD, ASAD, and APD in the current sample were 38.1%, 60.0%, and 
15.1%, respectively. ANOVA showed that age significantly differed be-
tween PA levels (F(2, 469) = 5.04, p ≤ 0.007); highly-active participants 
were significantly younger than low-active participants (mean differ-
ence=− 1.81, p ≤ 0.006; d = 0.38, 95%CI: 0.13, 0.62). 
3.1. Sex-Related differences in exposure & outcomes 
Independent samples t-tests showed that, compared to males, fe-
males reported significantly greater SPA (t(463)=6.61, p<0.001; d = 0.64, 
95%CI: 0.44, 0.83) and symptoms of GAD (t(468)=5.32, p<0.001; d =
0.51, 95%CI: 0.32, 0.70), SAD (t(468)=2.69, p ≤ 0.007; d = 0.26, 95%CI: 
0.07, 0.45), and PD (t(429.67)=3.34, p ≤ 0.001; d = 0.30, 95%CI: 0.11, 
0.49), and significantly lower estimated energy expenditure 
(t(284.34)=− 3.46, p ≤ 0.001; d = 0.33, 95%CI: 0.14, 0.52). Logistic 
regression showed that females had significantly greater odds of AGAD 
(OR=2.52, 95%CI: 1.67, 3.81, p<0.001), ASAD (OR=1.59, 95%CI: 1.09, 
2.33, p<0.02), and APD (OR=2.67, 95%CI: 1.44, 4.95, p ≤ 0.002). 
3.2. Differences in symptom severity and SPA by PA level 
ANCOVA adjusted for age and gender showed that symptoms of GAD 
(F(2, 465)=3.03, p ≤ 0.049) and SAD (F(2, 465)=3.06, p ≤ 0.048) and SPA 
(F(2, 460)=3.90, p ≤ 0.021) significantly differed between PA levels. 
Bonferonni-corrected post-hoc tests showed that GAD symptoms were 
significantly greater among low-active compared to highly-active (mean 
difference=0.98, p ≤ 0.043; d = 0.36, 95%CI: 0.12, 0.60). SAD symp-
toms were non-significantly greater among low-active compared to 
highly-active (mean difference=1.20, p ≥ 0.064; d = 0.30, 95%CI: 0.06, 
0.55). SPA was significantly greater among low-active compared to 
moderately-active (mean difference=3.49, p ≤ 0.048; d = 0.24, 95%CI: 
− 0.01, 0.50) and highly-active (mean difference=3.65, p ≤ 0.027; d =
0.33, 95%CI: 0.09, 0.58). PD symptoms did not significantly differ 
between PA levels (F(2, 465)=2.34, p ≥ 0.098). 
3.3. Associations between PA level and analogue anxiety disorder status 
3.3.1. Analogue GAD 
In crude logistic regression models, moderately-active and highly- 
active showed ~28% (OR=0.72, 95%CI: 0.43, 1.20, p>0.20) and 
~42% (OR=0.58, 95%CI: 0.35, 0.94, p ≤ 0.027) lower odds of AGAD, 
respectively. After adjustment for age, gender, and smoking status, 
moderately-active and highly-active showed ~29% (OR=0.71, 95%CI: 
0.42, 1.20, p>0.20) and ~37% (OR=0.63, 95%CI: 0.38, 1.06, p>0.07) 
lower odds of AGAD, respectively. Gender and smoking were significant 
covariates; females and smokers showed ~163% (OR=2.63, 95%CI: 
1.72, 4.00, p<0.001) and 151.0% (OR=2.51, 95%CI: 1.40, 4.50, p ≤
0.002) greater odds of AGAD, respectively. 
3.3.2. Analogue SAD 
In crude logistic regression models, moderately-active and highly- 
active showed ~32% (OR=0.68, 95%CI: 0.40, 1.16, p>0.15) and 
~35% (OR=0.65, 95%CI: 0.39, 1.07, p>0.08) lower odds of ASAD, 
respectively. After adjustment for age, gender, and smoking status, 
moderately-active and highly-active showed ~33% (OR=0.67, 95%CI: 
0.39, 1.14, p>0.14) and ~34% (OR=0.67, 95%CI: 0.40, 1.12, p>0.12) 
lower odds of ASAD. Gender was a significant covariate; females showed 
~61% greater odds of ASAD (OR=1.61, 95%CI: 1.09, 2.38, p<0.02). 
3.3.3. Analogue PD 
In crude logistic regression models, moderately-active and highly- 
active showed 37% (OR=0.63, 95%CI: 0.33, 1.21, p>0.16) and ~51% 
(OR=0.49, 95%CI: 0.26, 0.93, p<0.03) lower odds of APD. After 
adjustment for age, gender, and smoking status, moderately-active and 
highly-active showed ~38% (OR=0.62, 95%CI: 0.32, 1.23, p>0.17) and 
~50% (OR=0.50, 95%CI: 0.26, 0.98, p ≤ 0.044) lower odds of APD. 
Gender and smoking status were significant covariates; females and 
smokers showed 194% (OR=2.94, 95%CI: 1.52, 5.56, p ≤ 0.001) and 
300% (OR=4.00, 95%CI: 2.07, 7.74, p<0.001) greater odds of APD, 
respectively. 
3.4. Mediation 
Tables 3, 4, and 5 show output of mediation analysis for AGAD, 
ASAD, and APD, respectively. The pure indirect effect significantly 
accounted for 58.2% (p ≤ 0.021) and 47.9% (p ≤ 0.012) of the total 
effect of PA on AGAD and ASAD, respectively, and non-significantly 
accounted for 21.3% (p = 0.170) of the total effect of PA on APD. 
These associations were not statistically significant in sensitivity ana-
lyses controlling for depressive symptoms (Supplementary Tables 1–3). 
Table 1 
Explanation of the decomposition of potential effects.  
Total effect The overall effect of physical activity on mental health 
Controlled direct 
effect 
The direct effect of physical activity on mental health that was 
not explained by social physique anxiety 
Reference 
interaction 
The effect of physical activity on mental health due to the 
interaction with social physique anxiety 
Mediated 
interaction 
The effect of physical activity on mental health due to both 
mediation and interaction with social physique anxiety 
Pure indirect effect The effect of physical activity on mental health that was 
‘transferred’ through social physique anxiety  
Table 2 







Age (years) 23.5 (5.3) 23.1 (4.5) 23.2 (4.8) 
PDSQ-GAD 3.1 (3.2) 4.8 (3.3)*** 4.2 (3.3) 
PDSQ-SAD 4.7 (4.2) 5.8 (4.2)** 5.4 (4.2) 
PDSQ-PD 0.9 (1.7) 1.5 (2.1)** 1.3 (2.0) 
Comorbid GAD-SAD (n, 
%) 
38 (22.1%) 114 (38.3%)*** 152 (32.3%) 
Comorbid GAD-PD (n,%) 11 (6.4%) 48 (16.1%)** 59 (12.6%) 
Comorbid SAD-PD (n,%) 14 (8.1%) 46 (15.4%)* 60 (12.8%) 
SPA 34.0 (11.2) 41.2 (11.2)*** 38.6 (11.7) 
PA (kcals/wk) 297.4 (61.9) 279.9 (46.8)** 286.3 (53.4) 
*p < 0.05; **p < 0.01; ***p < 0.001 for comparison between males and females. 
Abbreviations: PDSQ-GAD=Psychiatric Diagnostic Screening Questionnaire- 
Generalized Anxiety Disorder subscale; PDSQ-SAD=Psychiatric Diagnostic 
Screening Questionnaire-Social Anxiety Disorder subscale; PDSQ-PD=Psychi-
atric Diagnostic Screening Questionnaire-Panic Disorder subscale; SPA=Social 
Physique Anxiety; PA=Physical activity; kcals=kilocalories; wk=week. 
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Mediation analyses stratified by gender did not reveal any sex-related 
differences (Supplementary Tables 4–6). 
4. Discussion 
Largely consistent with hypotheses, these cross-sectional findings 
showed that symptoms of GAD and SAD, but not symptoms of PD, 
significantly differed by PA levels, with lower anxiety disorder symp-
toms reported among higher levels of self-reported PA. Further, PA was 
associated with lower odds of AGAD, SAD, and PD, but findings were not 
statistically significant after adjusting for age, gender, and smoking 
status. Mediation analyses showed that 58.2% and 47.9% of the total 
effects of PA on AGAD and ASAD, respectively, were mediated by SPA. 
However, these findings were no longer statistically significant after 
more fully adjusting for depressive symptoms. Though females showed 
significantly greater odds of AGAD, ASAD, and APD, mediation findings 
did not differ based on gender. To the authors’ knowledge, this is the 
first study to demonstrate the mediating effect of SPA on associations 
between PA and any anxiety disorder, findings that may have critical 
implications for physical activity intervention among young adults with 
elevated anxiety disorder symptoms. These findings should be inter-
preted with some caution, particularly given that cross-sectional medi-
ation designs can be problematic due to likelihood of biased estimates 
(Maxwell and Cole, 2007; VanderWeele, 2016; Winer et al., 2016). 
These points are discussed in more detail in the following sections. 
Anxiety disorders are highly prevalent among young adults, with 
global prevalence rates among this age group of ~5.1% (Baxter et al., 
2013). However, the prevalence of potentially meaningful subclinical 
symptom severity (i.e., AGAD, ASAD, APD) is largely unknown. Herein, 
the prevalence rates of AGAD, ASAD, and APD were quite high at 38.1%, 
60.0%, and 15.1%, respectively. Given that there is no standard, 
prescribed treatment paradigm for such subclinical symptoms (i.e., it is 
unlikely that a clinician would/should prescribe a frontline therapy to 
an individual without a clinical diagnosis), it is imperative to identify 
accessible, potentially low-cost and low-risk alternative therapeutic 
options that may be ‘prescribed’ or ‘self-prescribed’ at large-scale. 
Regular PA is one such potentially low-cost, accessible, alternative 
therapies for which there are few, if any, negative side effects, unlike 
most frontline treatments. 
Herein, highly-active individuals reported significantly lower 
symptoms of GAD and SAD compared to low-active individuals; the 
magnitude of these differences exceeded 0.25SD at 0.36SD and 0.30SD 
for GAD and SAD, respectively. However, symptoms of PD did not 
significantly differ between PA levels. Inconsistent findings for PD may 
have resulted from the relatively low prevalence of PD in this sample. 
Additionally, these inconsistent findings may highlight that etiological 
underpinnings of these anxiety disorders and/or age of onset are 
differentially associated with PA behavior. For example, although this 
sample was comprised of young adults, the sample age range includes 
ages beyond the typical age of onset for SAD, within the range for PD, 
and before the typical age of onset for GAD. Though speculative, it is 
plausible that, because the age of onset of PD is within the current age 
range, emerging PD symptoms may have resulted in avoidance of ex-
ercise due to similarities of sensations experienced during exercise and 
those characteristic of panic attacks (i.e., increased heart rate, perspi-
ration, and respiration; also the premise of exercise as exposure therapy 
for PD), which may have reduced variability in PA. The differences in 
findings across anxiety disorders support future investigations of puta-
tive mechanisms underlying PA—Anxiety relationships. 
Further, PA was associated with 29%− 50% reductions in odds across 
analogue GAD, SAD, and PD statuses; however, in transparency, these 
findings were not statistically significant after adjustment for age, 
gender, and smoking status (these covariates are discussed later). The 
magnitude of these associations was consistent with previous associa-
tions between PA and symptoms of GAD (r=− 0.07) and SAD (r=− 0.12) 
reported among ~1000 US young adult women (Herring et al., 2014b) 
these odds reductions are also comparable to recent meta-analytic evi-
dence of associations between PA and reduced odds of any anxiety 
disorder (33.7%) and GAD (45.6%) (McDowell et al., 2019). Collec-
tively, these and previous findings support that PA interventions to 
combat anxiety disorders and symptoms may be particularly important, 
especially among young adults with elevated symptoms indicative of a 
potential anxiety disorder; intervening with PA at this point in the 
severity spectrum may prevent/reduce future anxiety-related burden 
(McDowell et al., 2019). 
To this end, because less than 25% of the US population meets rec-
ommended levels of PA (Bennie et al., 2020), there is a need to identify 
modifiable variables that may help to improve engagement in, mainte-
nance of, and response to PA, particularly among those with subclinical 
or clinical impairments in mental health. Previous evidence has sup-
ported inverse associations of PA and SPA (Brunet and Sabiston, 2009; 
McAuley et al., 2002), and the protective effects of PA on anxiety dis-
orders (McDowell et al., 2019). Although SPA is highly comorbid with 
other mental health disorders like eating disorders (Pallister and Waller, 
2008), less is known regarding associations between SPA and anxiety 
disorders or how SPA may influence associations between PA and anx-
iety disorder symptoms. 
Herein, SPA was associated with both PA and anxiety disorder 
symptoms and status; importantly, associations between PA and AGAD 
and ASAD status were partially mediated by SPA. These findings are 
consistent with previous evidence showing that physical self-esteem and 
self-concept, other body-related social-cognitive factors, mediated as-
sociations between PA and anxiety disorder symptoms among ~1000 US 
young adult women (Herring et al., 2014b). However, when mediation 
models were more fully adjusted for symptoms of Major Depressive 
Disorder (MDD), the reported associations were no longer statistically 
significant. Given the likelihood of overlapping etiological factors 
Table 3 
Decomposition of the overall effect of physical activity on analogue generalized 
anxiety disorder.   
β 95% CI P-value 
Total effect − 0.368 − 0.805 to 0.070 0.099 
Controlled direct effect − 0.140 − 0.428 to 0.147 0.338 
Reference interaction − 0.041 − 0.559 to 0.476 0.876 
Mediated interaction 0.028 − 0.202 to 0.258 0.810 
Pure indirect effect − 0.214 − 0.396 to − 0.033 0.021 
Adjusted for age, sex, and smoking. 
Table 4 
Decomposition of the overall effect of physical activity on analogue social 
anxiety disorder.   
β 95% CI P-value 
Total effect − 0.555 − 0.941 to − 0.169 0.005 
Controlled direct effect − 0.092 − 0.304 to 0.120 0.395 
Reference interaction − 0.366 − 0.776 to 0.044 0.080 
Mediated interaction 0.169 − 0.048 to 0.386 0.127 
Pure indirect effect − 0.266 − 0.473 to − 0.059 0.012 
Adjusted for age, sex, and smoking. 
Table 5 
Decomposition of the overall effect of physical activity on analogue panic 
disorder.   
β 95% CI P-value 
Total effect − 0.493 − 0.846 to − 0.139 0.006 
Controlled direct effect − 0.458 − 0.855 to − 0.060 0.024 
Reference interaction 0.094 − 0.283 to 0.470 0.626 
Mediated interaction − 0.024 − 0.213 to 0.166 0.807 
Pure indirect effect − 0.105 − 0.255 to 0.045 0.170 
Adjusted for age, sex, and smoking. 
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among the anxiety disorders investigated here and MDD (i.e., mono-
aminergic dysregulation), it is plausible that inclusion of these outcomes 
together in analytical models could bias (i.e., overestimate or underes-
timate) the ‘true’ association with PA if, indeed, those etiological factors 
are among the mechanisms that underpin salutary benefits of PA for a 
given condition. Additionally, temporality, or temporal ordering, is 
difficult to establish in cross-sectional mediation designs. However, 
there is a strong epidemiological literature to show that PA is associated 
with lower prevalence and incidence of anxiety disorders (McDowell 
et al., 2019), and exercise training has significantly improved outcomes 
among adults with anxiety disorders (Herring et al., 2012), providing 
support that the exposure of PA plausibly precedes the outcome of 
anxiety disorders. 
It also is plausible that young adults may use PA strategically to 
enhance their physical appearance (Thompson and Chad, 2002), 
thereby improving SPA and, subsequently, symptoms of SAD and GAD. 
Though a previous report showed significant associations between 
perceptions of appearance and symptoms of GAD and SAD, PA was not 
significantly associated with perceptions of appearance (Herring et al., 
2014b). As stated earlier, PA is associated with reduced odds of anxiety 
disorders and protects against the development of anxiety disorders 
(McDowell et al., 2019); thus, PA involvement may protect against the 
development of SPA as well. 
Conversely, SPA may predispose individuals to aversion to PA. Given 
that SPA is negatively associated with self-efficacy (Marquez and 
McAuley, 2001) and motivation (Thøgersen-Ntoumani and Ntoumanis, 
2007), it is plausible that young adults with elevated SPA may have less 
motivation for PA. However, previous evidence showed that individuals 
with elevated SPA were not deterred from the performance of regular PA 
(Kowalski et al., 2001). The present findings highlight both the need for 
further consideration of SPA as a modifiable factor to enhance engage-
ment in and maintenance of PA to potentially improve anxiety symp-
toms and disorders, and the need for future research into the extent to 
which SPA may influence anxiety response to acute and chronic 
exercise. 
Young adult women reported significantly lower physical activity, 
greater severity of GAD, SAD, and PD symptoms and SPA, and showed 
167%, 159%, and 59% greater odds of APD, AGAD, and ASAD, 
respectively. Based on a minimally important difference of 0.5SD 
(Norman et al., 2003), the magnitude of differences between GAD 
symptom severity (d = 0.51) and SPA (d = 0.64) between females and 
males is potentially clinically meaningful. There appeared to be no 
difference in the mediating effects of SPA on associations between PA 
and anxiety disorders between males and females. However, given the 
clearly worse PA, anxiety disorder, and SPA profile among women, 
future research in large samples of women, particularly those with 
anxiety symptomatology, is needed. 
Consistent with previous evidence showing both significant associ-
ations between smoking and anxiety symptoms and disorders (Moylan 
et al., 2012) and smoking status as a significant covariate in models of 
associations between PA and incident GAD (McDowell et al., 2018), 
smoking was a significant covariate in all models of PA and AGAD and 
APD. Smokers showed 151% and 300% greater odds of AGAD and APD, 
respectively. Given previous evidence of positive effects of regular PA 
and exercise on smoking cessation among adults with high anxiety 
sensitivity (Smits et al., 2016), PA interventions among smokers with 
subclinical or clinical anxiety symptomatology may be particularly 
important. 
5. Limitations 
The current findings should be interpreted with some caution in light 
of potential limitations. As stated earlier, cross-sectional mediation de-
signs can be problematic due to likelihood of biased estimates (Maxwell 
and Cole, 2007; VanderWeele, 2016; Winer et al., 2016). Though the 
rigor of the counterfactual approach to the mediation analyses was a 
potential strength, temporal ordering is difficult to establish in 
cross-sectional mediation designs. Self-reported PA may be subject to 
under-/over-reporting biases, and, though the anxiety disorder sub-
scales of the PDSQ demonstrated adequate internal consistency, the 
relatively low level of specificity is a potential limitation of these sub-
scales. Finally, a larger sample would have provided additional statis-
tical power to detect differences across anxiety disorder and PA statuses. 
6. Conclusions 
Notwithstanding potential limitations, the present findings support 
that higher physical activity is associated with lower anxiety disorder 
symptoms and odds of subclinical/analogue anxiety disorder status, 
particularly for GAD and SAD. Social physique anxiety appears to 
partially mediate associations between physical activity and GAD and 
SAD, and should be investigated/manipulated as a plausible mechanism 
to enhance the influence of regular physical activity on GAD and SAD. 
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